Cargando…
Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia
Primary myelofibrosis (PMF) is a type of cloned myeloproliferative neoplasm stemming from haematopoietic stem cells, and tends to transform to acute myeloid leukaemia (AML) in approximately 10–20% of cases over a 10-year period. The transformation into AML has a poor prognosis, with a median overall...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381513/ https://www.ncbi.nlm.nih.gov/pubmed/30616420 http://dx.doi.org/10.1177/0300060518820147 |
_version_ | 1783396512177324032 |
---|---|
author | Lin, Yan Lin, Rongrong Zhou, Guangquan Liu, Yue Dong, Weimin Cao, Yang Xie, Xiaobao Gu, Weiying |
author_facet | Lin, Yan Lin, Rongrong Zhou, Guangquan Liu, Yue Dong, Weimin Cao, Yang Xie, Xiaobao Gu, Weiying |
author_sort | Lin, Yan |
collection | PubMed |
description | Primary myelofibrosis (PMF) is a type of cloned myeloproliferative neoplasm stemming from haematopoietic stem cells, and tends to transform to acute myeloid leukaemia (AML) in approximately 10–20% of cases over a 10-year period. The transformation into AML has a poor prognosis, with a median overall survival of only 2.6 months in patients receiving supportive treatment. To date, treatment of AML transformation remains poor. The case of a 58-year-old female patient with AML transformed from PMF, who was treated with decitabine combined with all-trans retinoic acid, is reported. The patient had complete remission and a 17-month overall survival from initial diagnosis of transformed AML, with tolerated haematologic toxicity during the treatment period. |
format | Online Article Text |
id | pubmed-6381513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-63815132019-02-27 Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia Lin, Yan Lin, Rongrong Zhou, Guangquan Liu, Yue Dong, Weimin Cao, Yang Xie, Xiaobao Gu, Weiying J Int Med Res Case Reports Primary myelofibrosis (PMF) is a type of cloned myeloproliferative neoplasm stemming from haematopoietic stem cells, and tends to transform to acute myeloid leukaemia (AML) in approximately 10–20% of cases over a 10-year period. The transformation into AML has a poor prognosis, with a median overall survival of only 2.6 months in patients receiving supportive treatment. To date, treatment of AML transformation remains poor. The case of a 58-year-old female patient with AML transformed from PMF, who was treated with decitabine combined with all-trans retinoic acid, is reported. The patient had complete remission and a 17-month overall survival from initial diagnosis of transformed AML, with tolerated haematologic toxicity during the treatment period. SAGE Publications 2019-01-07 2019-02 /pmc/articles/PMC6381513/ /pubmed/30616420 http://dx.doi.org/10.1177/0300060518820147 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Reports Lin, Yan Lin, Rongrong Zhou, Guangquan Liu, Yue Dong, Weimin Cao, Yang Xie, Xiaobao Gu, Weiying Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia |
title | Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia |
title_full | Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia |
title_fullStr | Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia |
title_full_unstemmed | Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia |
title_short | Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia |
title_sort | decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381513/ https://www.ncbi.nlm.nih.gov/pubmed/30616420 http://dx.doi.org/10.1177/0300060518820147 |
work_keys_str_mv | AT linyan decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia AT linrongrong decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia AT zhouguangquan decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia AT liuyue decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia AT dongweimin decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia AT caoyang decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia AT xiexiaobao decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia AT guweiying decitabinecombinedwithalltransretinoicacidastreatmentinacaseofprimarymyelofibrosistransformingintoacutemyeloidleukaemia |